<< Prev  1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Next >>

FDA Accepts Upsher-Smith NDA for Epilepsy [103 Words] 05/22/2013

FDA Panel Backs Merck’s Low-dose Insomnia Drug [248 Words] 05/22/2013

Stakeholders Support Benefit-Risk Assessment Approach [314 Words] 05/22/2013

FDA Questions uChek Urine Analyzer Clearance [150 Words] 05/22/2013

FDA Approves Bausch & Lomb’s Trulign Toric Lens [120 Words] 05/22/2013

Ahead of Global Layoffs, Ranbaxy Touts Quality/Compliance Changes [499 Words] 05/22/2013

CSPI Wants St. John’s Wort Behind the Counter [132 Words] 05/22/2013

April NADA, ANADAs Posted in Animal Drug Regs [57 Words] 05/22/2013

Comments Sought on In Vitro Diagnostic Test Categorization [47 Words] 05/22/2013

CDRH Guidance on Expedited Device Submissions [89 Words] 05/21/2013

<< Prev  1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20  Next >>